$127 Million is the total value of Privium Fund Management (UK) Ltd's 69 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TDG | TRANSDIGM GROUP INC | $2,170,994 | +20.6% | 2,450 | 0.0% | 1.71% | +20.5% | |
| CRM | SALESFORCE INC | $2,069,158 | +7.0% | 9,833 | 0.0% | 1.63% | +7.0% | |
| EWC | ISHARES INCmsci cda etf | $1,933,858 | +2.1% | 55,908 | 0.0% | 1.52% | +2.1% | |
| XLC | SELECT SECTOR SPDR TR | $1,831,745 | +13.3% | 28,430 | 0.0% | 1.44% | +13.2% | |
| EWY | ISHARES INCmsci sth kor etf | $1,743,616 | +3.4% | 27,800 | 0.0% | 1.37% | +3.3% | |
| IYR | ISHARES TRu.s. real es etf | $1,720,736 | +3.6% | 19,983 | 0.0% | 1.36% | +3.5% | |
| UNH | UNITEDHEALTH GROUP INC | $1,667,540 | +1.4% | 3,500 | 0.0% | 1.31% | +1.3% | |
| FXO | FIRST TR EXCHANGE TRADED FDfinls alphadex | $1,643,859 | +2.4% | 43,650 | 0.0% | 1.29% | +2.4% | |
| ARB | ALTSHARES TRUSTmerger arbitrage | $1,595,144 | +0.2% | 62,900 | 0.0% | 1.26% | +0.1% | |
| XBI | SPDR SER TRs&p biotech | $1,552,430 | +10.6% | 18,790 | 0.0% | 1.22% | +10.6% | |
| XLU | SELECT SECTOR SPDR TRsbi int-utils | $1,449,728 | -3.7% | 22,400 | 0.0% | 1.14% | -3.7% | |
| UNVR | UNIVAR SOLUTIONS INC | $1,073,400 | +2.2% | 30,000 | 0.0% | 0.84% | +2.2% | |
| XLY | SELECT SECTOR SPDR TRsbi cons discr | $1,060,073 | +15.1% | 6,322 | 0.0% | 0.84% | +15.2% | |
| EWT | ISHARES INCmsci taiwan etf | $910,696 | +3.3% | 19,451 | 0.0% | 0.72% | +3.3% | |
| KRON | KRONOS BIO INC | $485,022 | +6.4% | 292,182 | 0.0% | 0.38% | +6.4% | |
| BKI | BLACK KNIGHT INC | $299,750 | +6.1% | 5,000 | 0.0% | 0.24% | +5.8% | |
| BXC | BLUELINX HLDGS INC | $279,923 | +38.4% | 2,976 | 0.0% | 0.22% | +38.4% | |
| TARA | PROTARA THERAPEUTICS INC | $271,787 | -32.2% | 119,730 | 0.0% | 0.21% | -32.3% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $225,044 | +71.6% | 177,200 | 0.0% | 0.18% | +71.8% | |
| GTX | GARRETT MOTION INC | $212,578 | +3.8% | 27,536 | 0.0% | 0.17% | +3.7% | |
| ALGOMA STL GROUP INC | $179,105 | -10.4% | 19,074 | 0.0% | 0.14% | -10.2% | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $147,975 | -1.6% | 116,516 | 0.0% | 0.12% | -0.8% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $94,932 | +18.3% | 117,200 | 0.0% | 0.08% | +19.0% | |
| AVRO | AVROBIO INC | $78,212 | -8.1% | 87,770 | 0.0% | 0.06% | -7.5% | |
| EPIX | ESSA PHARMA INC | $55,288 | -10.1% | 20,032 | 0.0% | 0.04% | -8.3% | |
| SPRB | SPRUCE BIOSCIENCES INC | $52,054 | -0.9% | 24,554 | 0.0% | 0.04% | 0.0% | |
| TSCAN THERAPEUTICS INC | $40,037 | -2.3% | 15,825 | 0.0% | 0.03% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-07-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALASKA AIR GROUP INC | 11 | Q3 2023 | 2.6% |
| CONTROLADORA VUELA COMP DE A | 11 | Q3 2023 | 1.7% |
| ALPHABET INC | 10 | Q3 2023 | 10.1% |
| COPA HOLDINGS SA | 9 | Q3 2023 | 1.8% |
| DELTA AIR LINES INC DEL | 8 | Q3 2023 | 2.7% |
| SPDR GOLD TR | 8 | Q4 2022 | 1.6% |
| ACELRX PHARMACEUTICALS INC | 8 | Q3 2022 | 0.0% |
| ISHARES INC | 7 | Q3 2023 | 5.4% |
| TECK RESOURCES LTD | 7 | Q3 2022 | 1.9% |
| ISHARES TR | 7 | Q3 2023 | 2.1% |
View Privium Fund Management (UK) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-10 |
| 13F-HR/A | 2022-03-25 |
View Privium Fund Management (UK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.